Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma (MREO) Shares Outstanding (2021 - 2025)

Historic Shares Outstanding for Mereo BioPharma (MREO) over the last 4 years, with Q3 2025 value amounting to $795.5 million.

  • Mereo BioPharma's Shares Outstanding rose 281.93% to $795.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $795.5 million, marking a year-over-year increase of 281.93%. This contributed to the annual value of $775.7 million for FY2024, which is 1062.59% up from last year.
  • Latest data reveals that Mereo BioPharma reported Shares Outstanding of $795.5 million as of Q3 2025, which was up 281.93% from $795.0 million recorded in Q2 2025.
  • Mereo BioPharma's 5-year Shares Outstanding high stood at $795.5 million for Q3 2025, and its period low was $624.9 million during Q1 2023.
  • For the 4-year period, Mereo BioPharma's Shares Outstanding averaged around $747.4 million, with its median value being $773.7 million (2024).
  • Data for Mereo BioPharma's Shares Outstanding shows a peak YoY increase of 1335.31% (in 2025) and a maximum YoY decrease of 281.93% (in 2025) over the last 5 years.
  • Mereo BioPharma's Shares Outstanding (Quarter) stood at $788.5 million in 2021, then dropped by 11.07% to $701.2 million in 2023, then rose by 10.63% to $775.7 million in 2024, then grew by 2.55% to $795.5 million in 2025.
  • Its Shares Outstanding was $795.5 million in Q3 2025, compared to $795.0 million in Q2 2025 and $795.0 million in Q1 2025.